Clinical Findings and Prognosis of Danon Disease. An Analysis of the Spanish Multicenter Danon Registry

Rev Esp Cardiol (Engl Ed). 2019 Jun;72(6):479-486. doi: 10.1016/j.rec.2018.04.035. Epub 2018 Aug 11.
[Article in English, Spanish]

Abstract

Introduction and objectives: Danon disease (DD) is caused by mutations in the LAMP2 gene. It is considered a multisystemic disease characterized by hypertrophic cardiomyopathy with pre-excitation and extreme hypertrophy, intellectual disability, myopathy, childhood presentation, and worse prognosis in men. There are scarce data on the clinical characteristics and prognosis of DD.

Methods: We analyzed the clinical records of patients with DD from 10 Spanish hospitals.

Results: Twenty-seven patients were included (mean age, 31 ± 19 years; 78% women). Male patients showed a high prevalence of extracardiac manifestations: myopathy (80%), learning disorders (83%), and visual alterations (60%), which were uncommon findings in women (5%, 0%, and 27%, respectively). Although hypertrophic cardiomyopathy was the most common form of heart disease (61%), the mean maximum wall thickness was 15 ± 7 mm and dilated cardiomyopathy was present in 12 patients (10 women). Pre-excitation was found in only 11 patients (49%). Age at presentation was older than 20 years in 16 patients (65%). After a median follow-up of 4 years (interquartile range, 2-9), 4 men (67%) and 9 women (43%) died or required a transplant. Cardiac disease and adverse events occurred later in women (37 ± 9 vs 23 ± 16 and 36 ± 20 vs 20 ± 11 years, respectively).

Conclusions: The clinical characteristics of DD differ substantially from traditional descriptions: age at presentation of DD is older, the disease is not multisystemic in women, and pre-excitation is infrequent.

Keywords: Alteraciones del aprendizaje; Danon disease; Enfermedad de Danon; Hypertrophic cardiomyopathy; Intellectual disability; Miocardiopatía hipertrófica; Miopatía; Myopathy; Pre-excitation; Preexcitación.

Publication types

  • Multicenter Study

MeSH terms

  • Adolescent
  • Adult
  • Cardiomyopathy, Hypertrophic / diagnosis
  • Cardiomyopathy, Hypertrophic / epidemiology
  • Cardiomyopathy, Hypertrophic / etiology*
  • Electrocardiography
  • Female
  • Glycogen Storage Disease Type IIb / complications
  • Glycogen Storage Disease Type IIb / diagnosis*
  • Glycogen Storage Disease Type IIb / genetics
  • Humans
  • Incidence
  • Lysosomal-Associated Membrane Protein 2 / genetics
  • Lysosomal-Associated Membrane Protein 2 / metabolism
  • Male
  • Mutation
  • Phenotype
  • Prognosis
  • Registries*
  • Retrospective Studies
  • Spain / epidemiology
  • Wolff-Parkinson-White Syndrome / diagnosis
  • Wolff-Parkinson-White Syndrome / epidemiology
  • Wolff-Parkinson-White Syndrome / etiology*
  • Young Adult

Substances

  • LAMP2 protein, human
  • Lysosomal-Associated Membrane Protein 2